1. Home
  2. NOTV vs CEE Comparison

NOTV vs CEE Comparison

Compare NOTV & CEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • CEE
  • Stock Information
  • Founded
  • NOTV 1974
  • CEE 1990
  • Country
  • NOTV United States
  • CEE Germany
  • Employees
  • NOTV N/A
  • CEE N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • CEE Finance Companies
  • Sector
  • NOTV Health Care
  • CEE Finance
  • Exchange
  • NOTV Nasdaq
  • CEE Nasdaq
  • Market Cap
  • NOTV 95.2M
  • CEE 79.2M
  • IPO Year
  • NOTV 1997
  • CEE N/A
  • Fundamental
  • Price
  • NOTV $3.94
  • CEE $11.59
  • Analyst Decision
  • NOTV Strong Buy
  • CEE
  • Analyst Count
  • NOTV 3
  • CEE 0
  • Target Price
  • NOTV $5.92
  • CEE N/A
  • AVG Volume (30 Days)
  • NOTV 1.2M
  • CEE 22.0K
  • Earning Date
  • NOTV 02-05-2025
  • CEE 01-01-0001
  • Dividend Yield
  • NOTV N/A
  • CEE 3.86%
  • EPS Growth
  • NOTV N/A
  • CEE N/A
  • EPS
  • NOTV N/A
  • CEE N/A
  • Revenue
  • NOTV $490,739,000.00
  • CEE N/A
  • Revenue This Year
  • NOTV $7.14
  • CEE N/A
  • Revenue Next Year
  • NOTV $5.73
  • CEE N/A
  • P/E Ratio
  • NOTV N/A
  • CEE N/A
  • Revenue Growth
  • NOTV N/A
  • CEE N/A
  • 52 Week Low
  • NOTV $1.23
  • CEE $7.80
  • 52 Week High
  • NOTV $11.42
  • CEE $10.32
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 53.75
  • CEE 48.85
  • Support Level
  • NOTV $4.63
  • CEE $11.56
  • Resistance Level
  • NOTV $6.48
  • CEE $12.26
  • Average True Range (ATR)
  • NOTV 0.73
  • CEE 0.38
  • MACD
  • NOTV 0.05
  • CEE -0.08
  • Stochastic Oscillator
  • NOTV 30.33
  • CEE 44.03

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

About CEE The Central and Eastern Europe Fund Inc. (The)

CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.

Share on Social Networks: